Literature DB >> 11164944

Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension.

J F Peng1, M I Phillips.   

Abstract

Rats exposed chronically to mild cold (5 degrees C/41 degrees F) develop hypertension. This cold-induced hypertension (CIH) is an environmentally induced, non-surgical, non-pharmacological and non-genetic model for studying hypertension in rats. The blood renin angiotensin system (RAS) appears to play a role in both initiating and maintaining the high blood pressure in CIH. The goal of the present study was to evaluate the role of brain angiotensin type 1 and type 2 receptors (AT1R and AT2R) in CIH. Sprague-Dawley adult male rats were used. Thirty-six rats were kept in a cold room at 5 degrees C and the other 36 were kept at 24 degrees C as controls. Systolic blood pressure (SBP) was recorded by tail cuff. The SBP was elevated in rats exposed to cold within 1 week (n=12, P>0.05), significantly increased at 3 weeks (P<0.05) and reached a maximum (125%) at 5 weeks (P<0.01). Three subgroups of the cold-treated and the controls were sacrificed at 1, 3 and 5 weeks. Specific brain sections were removed, either for reverse transcription polymerase chain reaction (RT-PCR) to measure mRNA, or for autoradiography to measure receptor binding for AT1R and AT2R. The AT1R mRNA was increased significantly in hypothalamus and brainstem after the first week in cold-treated rats and was maintained throughout the time of exposure to cold (n=6, P<0.01). AT1R binding significantly increased initially in hypothalamus and thereafter in brainstem. The mRNA and the receptor binding for AT2R decreased significantly (P<0.01, n=6) in nucleus of inferior olive and locus coeruleus of brainstem in cold-treated rats after exposure to cold. The experiments show differential regulation of RAS components, AT1R and AT2R, in different brain areas in cold-exposed rats and provide evidence that up-regulated AT1R and down-regulated AT2R in different brain areas are involved in CIH. The opposing directions of expression of AT1R and AT2R suggest that they play counterbalancing roles in brain function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164944     DOI: 10.1016/s0167-0115(00)00218-4

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  11 in total

1.  Sensitization of slow pressor angiotensin II (Ang II)-initiated hypertension: induction of sensitization by prior Ang II treatment.

Authors:  Baojian Xue; Zhongming Zhang; Ralph F Johnson; Alan Kim Johnson
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

Review 2.  AT2 receptor signaling and sympathetic regulation.

Authors:  Lie Gao; Irving H Zucker
Journal:  Curr Opin Pharmacol       Date:  2010-12-13       Impact factor: 5.547

Review 3.  Angiotensin II receptors and drug discovery in cardiovascular disease.

Authors:  Chiranjib Dasgupta; Lubo Zhang
Journal:  Drug Discov Today       Date:  2010-12-13       Impact factor: 7.851

4.  Ontogeny of angiotensin type 2 and type 1 receptor expression in mice.

Authors:  Juan Gao; Jie Chao; Karma-Jaya K Parbhu; Li Yu; Liang Xiao; Fei Gao; Lie Gao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2012-04-22       Impact factor: 1.636

5.  Developmental changes in AT1 and AT2 receptor-protein expression in rats.

Authors:  Li Yu; Mingqi Zheng; Wei Wang; George J Rozanski; Irving H Zucker; Lie Gao
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2010-08-31       Impact factor: 1.636

Review 6.  Brain angiotensin II: new developments, unanswered questions and therapeutic opportunities.

Authors:  Juan M Saavedra
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

Review 7.  Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

Authors:  John W Wright; Brent J Yamamoto; Joseph W Harding
Journal:  Prog Neurobiol       Date:  2007-11-19       Impact factor: 11.685

8.  Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial.

Authors:  Ehsan Bahramali; Negar Firouzabadi; Ilnaz Yavarian; Mohammad Reza Hooshangi Shayesteh; Nasrallah Erfani; Ali Alavi Shoushtari; Roja Asadpour
Journal:  Eur J Clin Pharmacol       Date:  2016-06-05       Impact factor: 2.953

9.  Angiotensin II AT(1) receptor blockade selectively enhances brain AT(2) receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats.

Authors:  C Bregonzio; A Seltzer; I Armando; J Pavel; J M Saavedra
Journal:  Stress       Date:  2008-11       Impact factor: 3.493

10.  Peripherally administered angiotensin II AT1 receptor antagonists are anti-stress compounds in vivo.

Authors:  Jaroslav Pavel; Julius Benicky; Yuki Murakami; Enrique Sanchez-Lemus; Juan M Saavedra
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.